Genomic epidemiology of SARS-CoV-2 in large university hospital cohort: the UnCoVER-Brazil project.


Journal

Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737

Informations de publication

Date de publication:
20 07 2023
Historique:
medline: 7 8 2023
pubmed: 20 7 2023
entrez: 20 7 2023
Statut: epublish

Résumé

This work aimed to study the role of different SARS-CoV-2 lineages in the epidemiology of multiple waves of the COVID-19 pandemic in Ribeirão Preto (São Paulo state), with comparison within Brazil and globally. Viral genomic sequencing was combined with clinical and sociodemographic information of 2,379 subjects at a large Brazilian hospital. On the whole 2,395 complete SARS-CoV-2 genomes were obtained from April 2020 to January 2022. We report variants of concern (VOC) and interest (VOI) dynamics and the role of Brazilian lineages. We identified three World Health Organization VOCs (Gamma, Delta, Omicron) and one VOI (Zeta), which caused distinct waves in this cohort. We also identified 47 distinct Pango lineages. Consistent with the high prevalence of Gamma in Brazil, Pango lineage P.1 dominated infections in this cohort for half of 2021. Each wave of infection largely consisted of a single variant group, with each new group quickly and completely rising to dominance. Despite increasing vaccination in Brazil starting in 2021, this pattern was observed throughout the study and is consistent with the hypothesis that herd immunity tends to be SARS-CoV-2 variant-specific and does not broadly protect against COVID-19.

Identifiants

pubmed: 37469288
doi: 10.1017/S095026882300119X
pii: S095026882300119X
pmc: PMC10620948
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e126

Références

Emerg Microbes Infect. 2022 Dec;11(1):172-181
pubmed: 34842496
Viruses. 2021 Apr 21;13(5):
pubmed: 33919314
Virus Evol. 2022 Jul 27;8(2):veac064
pubmed: 35996592
Wellcome Open Res. 2021 May 19;6:121
pubmed: 34095513
Emerg Infect Dis. 2022 Mar;28(3):730-733
pubmed: 35133956
Lancet. 2022 Jun 25;399(10344):2351-2380
pubmed: 35405084

Auteurs

Felipe Santos de Carvalho (FS)

Social Medicine Department, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Infectious Diseases Division, Internal Medicine Department, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Medicine Department, Federal University of São Carlos, São Carlos, Brazil.

Sarah Danielle Slack (SD)

Infectious Diseases Division, Internal Medicine Department, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Oncology and Imaging Department, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

Francisco Barbosa-Júnior (F)

Social Medicine Department, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

Mateus Rennó de Campos (MR)

Social Medicine Department, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Epidemiological Surveillance Service, University Hospital of Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

Guilherme Silveira Castro (GS)

Social Medicine Department, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

Sabrina Baroni (S)

Oncology and Imaging Department, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

Livia Mara Torres Bueno (LMT)

Oncology and Imaging Department, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

Fernanda Borchers Coeli (FB)

Oncology and Imaging Department, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

Aparecida Yulie Yamamoto (AY)

Virology Laboratory, University Hospital of Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

Jorgete Maria Silva (JM)

Social Medicine Department, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Epidemiological Surveillance Service, University Hospital of Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

Rodrigo do Tocantins Calado (RDT)

Oncology and Imaging Department, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

Benedito Antônio Lopes Fonseca (BAL)

Infectious Diseases Division, Internal Medicine Department, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

Leandro Machado Colli (LM)

Oncology and Imaging Department, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

Fernando Bellissimo-Rodrigues (F)

Social Medicine Department, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH